Jim Cramer Discussed These 12 Stocks Recently

4. Novo Nordisk A/S (NYSE:NVO)

Number of Hedge Fund Holders: 64

Noting the stock’s decline in the year, a caller asked if Novo Nordisk A/S (NYSE:NVO) was a buy. In response, Cramer said:

“I do…. It got low enough. When it hit 3.6% yield, it was low enough. Apparently, they’re doing exactly what President Trump wants. I am a buyer at this point in Novo Nordisk, though of course I do like Eli Lilly more, but this stock has come down enough.”

Novo Nordisk (NYSE:NVO) is focused on researching, developing, manufacturing, and distributing pharmaceutical products. For context, over the past year, NVO stock went down more than 47% while LLY stock gained a little over 1%. During an episode of Squawk on the Street aired in January, Cramer remarked:

“Now we don’t know what the President’s going to do. Is Novo Nordisk, cause they make some stuff but it’s a Danish company, where are they going to be in the tariffs?… Yeah because you already have Zepbound, why do you need Wegovy?”